John Cleese takes us on a tour of a laughter therapy practice in India.
Laughter promotes stress reduction, community bonding, stronger immune system... and joy. What a simple solution!
John Cleese takes us on a tour of a laughter therapy practice in India.
Laughter promotes stress reduction, community bonding, stronger immune system... and joy. What a simple solution!
These new medical schools are seeking to address an imbalance in
American medicine that has been growing for a quarter century.
Many bright students were fleeing to offshore medical schools, or giving up hope entirely, when they could not get into domestic schools.
In a weird aberration of "outsourcing", the medical field was outsourcing medical education to foreign countries, and then hiring foreign nationals to work in our American healthcare system, presumably at lower rates and longer hours.
During the 1980s and '90s only one new medical school was established.
"Huge numbers of qualified American kids were not getting into American medical schools or going abroad to study," Dr. Lawrence G. Smith, dean of the proposed Hofstra University School of Medicine, in Hempstead, N.Y., which is not yet recruiting students, said last week. "I think it was a kind of wake-up call."
The
proliferation of new schools is also a market response to a rare
convergence of forces:
Colleges serve a "Gatekeeping Function" as well as education of new practitioners. By carefully limiting the number of trained professionals, those with established careers have less competition -- and that can be important to personal care services that must maintain a full staff even when they have a light load of patients. Under-staffing also causes long delays in getting an appointment, and has healthcare consequences when care is delayed.
If all the schools being proposed actually opened, they would amount to an 18 percent increase in the 131 medical schools across the country.
Read more at the REFERENCE SOURCE: New York Times
"This is important, because surgery is not often affordable or reimbursed by insurance," said leading scientist Dr. Donna Ryan. "In fact, many medical treatments are frequently not reimbursed by insurance if they are for obesity. So this research is needed to show that primary care doctors are capable of helping obese patients lose weight to improve health, even those with extreme obesity. "
Ryan said losing only five-percent of body weight can reap healthy benefits for the extremely obese, and nearly 61-percent of those in her clinical trial achieved that. More than 40-percent lost 10-percent body weight or more.
Physicians Trained in Intensive Medical Intervention
Ryan and her team spread out across Louisiana to recruit and train practicing physicians and their office staffs in eight cities in what she called "intensive medical intervention," in which physicians used a combination of medication, low-calorie diets and behavior changes. All of the techniques were endorsed by national guidelines for obesity management. Training of physicians and their staffs took about a day and a half.
Funded by the Louisiana Office of Group Benefits, which provides health coverage for state employees, the research team contacted state employees, seeking participants to screen for and enroll in the trial. Nearly 400 participants enrolled in the two-year trial, called LOSS, using the nearest trained physicians.
About half of the participants received the intensive medical intervention, the other half received what Ryan called "usual care."
Program Starts with Low-calorie Liquid Diet
Those in the intense intervention group were immediately placed on a low-calorie liquid diet. They gradually moved to a low calorie, highly controlled diet using meal replacements, and received weight loss medication and group behavioral therapy that included lessons in exercise, activity, self-monitoring and recommendations for walking, water exercise and weight training. The group sessions were supervised by office staff.
Recommended Activities
Success in Daily Routine of Doctor's Practice
"We conducted this trial as close to the reality of a typical clinic setting as we could," Ryan said, "We didn't want to learn just if these strategies worked, but if they would work in the daily routine of a doctor's practice."
Challenge of Keeping Weight Off
Ryan noted that the continual challenge in weight loss
is keeping weight off, and that means sticking with a routine.
More than 50% of the LOSS participants stuck with it for two years or more, keeping much of the weight off, but Ryan said that does leave room for improving weight loss maintenance.
The LOSS trial results were published in the current issue of the Archives of Internal Medicine.
The Pennington Biomedical Research Center is a campus of the Louisiana State University System and conducts basic, clinical and population research.More information about recalled food products is available on the Food Safety and Inspection Service Web site at http://www.fsis.usda.gov/
The Hygienic Laboratory is the state of Iowa's environmental and public health laboratory, with facilities located at the University of Iowa's Research Campus in Iowa City and at the Iowa Lab Facilities in Ankeny, a Des Moines suburb. For more information about the laboratory and its programs and services, visit http://www.uhl.uiowa.edu.
Both humans and mice are particularly vulnerable to noise- and drug-induced hearing loss at young ages.
"The laboratory mouse is a well-established model for human hearing," says coauthor Kevin K. Ohlemiller, Ph.D., research associate professor of otolaryngology. "They possess similar inner ear anatomy and physiology and similar patterns of age-related, noise-induced and drug-related hearing loss."
Ohlemiller worked with Elizabeth A. Fernandez, then a doctoral student in the Program in Audiology and Communication Sciences, to see if loud noise and a low dose of kanamycin would exacerbate each other's effects. Because the first month of life is when mice are most vulnerable to noise and drugs that damage hearing, 20- to 30-day old mice were injected with either kanamycin or saline solution twice a day for 11 days. They were then exposed to 110 decibels of noise for 30 seconds.
Two surprising
findings arose.
First, this particular strain of mice was very
sensitive to noise-induced hearing loss. Significant loss of some
sensory cells in the ear resulted in permanent hearing damage, even
over the short time span.
Second, a regular, low dose of kanamycin completely protected the mice against this sensory cell damage and hearing loss. The protective effect of repeated doses persists for at least two days after the last injection, the scientists noted.
Researchers
plan to use these hearing research findings in a number of ways.
They can map
the genes in this strain of mice to determine what makes them so
noise-sensitive and possibly figure out how kanamycin protects sensory
cells in the ear.
In addition, the findings open up new possibilities
for clinical research.
Learning how kanamycin protects the ear's sensory cells could help scientists develop drugs with similar effects. Medications that protect the ears from damaging noise levels could benefit a wide range of groups, from soldiers to airline workers to premature babies.
Basic Science Research PLUS Clinical Problem & Practice
"This very dramatically points out the benefits
of having basic scientists who can take a clinical problem and find a
result opposite of what we expected," Clark says. "These results not
only energize laboratory scientists and begin new lines of research,
but they also have implications for clinical practice. This has been an
amazing sequence of events, to start a project in a helicopter and end
up under a microscope."
Fernandez EA, Ohlemiller KK, Gagnon PM, Clark WW. Protection against noise-induced hearing loss in young CBA/J mice by low-dose kanamycin. Journal of the Association for Research in Otolaryngology. Jan. 22, 2010 (advance online publication).
Funding from National Institutes of Health and the Washington University School of Medicine in St. Louis Department of Otolaryngology supported this research.
For 40 years in this country we've been trying to get individuals to reduce the amount of sodium we consume and it hasn't worked.
The report found that certain core needle biopsies could distinguish between malignant and benign lesions approximately as accurately as open surgical biopsy, which is commonly considered the "gold standard" method of evaluating suspicious lesions.
Core needle biopsies have a much lower risk of severe complications than open surgical procedures, researchers found in a report published this month in Annals of Internal Medicine.
The report also found that women who are initially diagnosed with breast cancer by surgical biopsy are more likely to undergo multiple surgical procedures during treatment than women who are initially diagnosed with breast cancer by core needle biopsy.
"One challenge of providing appropriate care for patients is finding balance between the accuracy of a test or procedure and causing the least harm and burden to patients," said AHRQ Director Carolyn M. Clancy, M.D. "This report indicates that core needle biopsy may strike that balance in many instances. Patients should continue to speak to their doctor when making important decisions about testing, and use all available information to make the decision that is right for them."
Open surgical biopsies, which involve removing a sample of tissue from the suspicious area through a surgical incision, are highly accurate. The procedure may be performed under general anesthesia, sedation plus local anesthesia, or local anesthesia only. But, while generally considered safe, open surgical biopsies are surgical procedures that, like all surgeries, carry a small amount of risk. Given that only a fraction of women who undergo breast biopsy procedures are diagnosed with cancer, use of traditional biopsy leads to large numbers of women who do not have cancer undergoing an invasive surgical biopsy.
By contrast, a core needle biopsy is a procedure that removes breast tissue through a hollow core needle inserted through the skin. The procedure is usually performed under local anesthesia. Multiple core-needle samples may be taken from the suspicious area.
Because it is less invasive, core-needle biopsy costs less than open surgical biopsy, consumes fewer resources, and generally is preferred by patients, according to the report.
The report found that recent technological improvements to core needle biopsy, including stereotactic guidance, ultrasound guidance and vacuum assistance, have improved the method's accuracy.
AHRQ's new report, Comparative Effectiveness of Core Needle and Open Surgical Biopsy for the Diagnosis of Breast Lesions, is the newest analysis from the Agency's Effective Health Care program. That program, authorized by the Medicare Prescription Drug, Improvement and Modernization Act, represents an important Federal effort to compare alternative treatments for health conditions and make the findings public. The program is intended provide information in order to help patients, doctors, nurses, and others choose the most effective treatments. Information, including the new report and summary guides for clinicians and patients, can be found at http://www.effectivehealthcare.ahrq.gov.
The interim final rule will help ensure that genetic information is not used adversely in determining health care coverage and will encourage more individuals to participate in genetic testing, which can help better identify and prevent certain illnesses.
"Echoing the late Senator Ted Kennedy, our efforts to
protect Americans undergoing genetic testing from having the results of
that testing used against them by their insurance companies is one of
the 'first major new civil rights' of the new century," said HHS
Secretary Kathleen Sebelius.
Consumer confidence in genetic testing can now grow and help researchers get a better handle on the genetic basis of diseases. Genetic testing will encourage the early diagnosis and treatment of certain diseases while allowing scientists to develop new medicines, treatments, and therapies.
The interim final rule
with request for comments and the notice of proposed rulemaking
implement Title I of the Genetic Information Nondiscrimination Act of
2008 (GINA). Under GINA, and the interim final rule, group health plans
and issuers in the group market cannot:
"Today's genetic technologies yield data that are vital to helping Americans make personal, medical decisions. It is essential that we protect such information and ensure it is not misused by health plans or insurers," said Labor Secretary Hilda L. Solis. "The rules issued today protect individuals against the unwarranted use of information related to their personal health because no one should have to fear that disclosure of their medical data will put their job or health coverage at risk."
Additionally, HHS, through its Office for Civil Rights (OCR), issued a notice of proposed rulemaking with a 60-day comment period, to propose changes to the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule to prohibit health plans from using or disclosing genetic information for underwriting purposes.
Please visit http://edocket.access.gpo.gov/2009/pdf/E9-22504.pdf to view the new regulations and www.dol.gov/ebsa for more information about them. For additional information on the OCR notice of proposed rulemaking, please visit: www.hhs.gov/ocr/privacy.